Navigation Links
Lupus Advocates Seek Increased Federal Response to Life-Changing, Life-Threatening Disease Affecting 1.5 Million Americans
Date:2/29/2008

WASHINGTON, Feb. 29 /PRNewswire-USNewswire/ -- Increased funding for sound biomedical research and education programs is critical to finding the causes of and eventually a cure for lupus and for improving the diagnosis and treatment of the life-diminishing and life-threatening disease. Approximately 300 individuals with lupus, their families, and health professionals from 37 states will deliver this message to 200 Members of the United States Congress on March 11 when the Lupus Foundation of America (LFA) conducts its Tenth Annual Advocacy Day in Washington, DC.

More than 1.5 million Americans have a form of lupus, an unbalanced immune system that can be destructive to any major organ or tissue in the body. Lupus can be very unpredictable and is potentially fatal, yet no satisfactory treatment or cure exists. It has been nearly 50 years since the U.S. Food and Drug Administration approved a new therapy for lupus.

As the foremost national nonprofit voluntary health organization dedicated to lupus, the LFA has for the past decade brought individuals affected by lupus and health professionals to Capitol Hill to advocate for increased government support for lupus research and education programs.

LFA advocates successfully stimulated a number of programs which have greatly expanded federal efforts to address lupus. From a small beginning ten years ago, the LFA nationwide grassroots network has grown substantially to approximately 80,000 lupus advocates, supporters and volunteers from every state in the country. These advocates send letters and email messages, make telephone calls, and visit congressional offices to educate elected officials on the impact of lupus.

LFA advocates have been effective in advancing lupus research and education programs conducted by the federal government, including:

-- coordinating efforts among the various federal agencies with an

interest in lupus;

-- securing millions of dollars for the first-ever comprehensive national

epidemiological study on lupus;

-- opening new sources of federal funding for biomedical research on

lupus;

-- obtaining changes in draft Social Security Disability regulations which

will enable more people disabled by lupus to receive benefits;

-- securing changes to regulations governing the Medicare Part D

Prescription Drug Benefit to pay for prescription drugs required to

treat lupus;

-- partnering with various agencies of the U.S. Department of Health and

Human Services to increase public recognition of the serious

consequences of lupus.

During LFA's 2008 Advocacy Day, advocates will urge lawmakers to support the Lupus Research, Education, Awareness, Communications, and Healthcare (REACH) Amendments Act (H.R. 1192 and S. 1359). The legislation, introduced by Rep. Kendrick Meek (D-FL) and Rep. Ileana Ros-Lehtinen (R-FL) in the House and Senator Patty Murray (D-WA) and Senator Robert Bennett (R-UT) in the Senate, when enacted will further federal efforts to combat lupus, address gaps in research, and heighten awareness of lupus symptoms and health effects among the public and health professionals.

About the Lupus Foundation of America

The LFA is the foremost national nonprofit voluntary health organization dedicated to finding the causes of and cure for lupus, and providing support, services and hope to all people affected by lupus. Founded in 1977, the LFA has a nationwide network of nearly 300 chapters and support groups and operates programs of research, education and advocacy. For more information about the lupus and LFA, go online to http://www.lupus.org or call toll-free 1-888-38-LUPUS to request a free brochure.


'/>"/>
SOURCE Lupus Foundation of America
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Preclinical study suggests organ-transplant drug may aid in lupus fight
2. Genes Boost Risk for Rheumatoid Arthritis, Lupus
3. The Will and Jada Smith Family Foundation and Maybelline Join Forces With the Lupus Foundation of America for a Star-studded Gala to Raise Awareness for Lupus
4. Better Lupus Treatments on the Horizon
5. Stars Shine on Butterflies Over Hollywood for Lupus Foundation of America
6. Clinical Trials for Lupus Underway After Decades of Drought
7. October is Lupus Awareness Month
8. New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs
9. Photo: New York Goes Orange for Pumpkin Festival and Lupus Awareness Month
10. Mayo Clinic shows therapy effective for reducing lupus flares
11. Research suggests targeted treatment strategies for lupus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... Empower Brokerage, located ... training and leads programs. , In February, 2017, Empower Brokerage introduced their new ... Partners is designed to teach how to maximize their sales efforts, as well ...
(Date:3/24/2017)... ... March 24, 2017 , ... “End Time GPS”: ... events will interrelate. “End Time GPS” is the creation of published author, Wesley ... while working on military munitions and space-vehicle projects. Now, at age ninety-one, he shares ...
(Date:3/24/2017)... ... ... Adventures of Joey, The Dog Who Barks at Puddles”: a boisterous story about a ... God intended. “The Adventures of Joey, The Dog Who Barks at Puddles” is the ... writing, especially about truth and human behavior. , Published by Christian Faith Publishing, Patti ...
(Date:3/23/2017)... Texas (PRWEB) , ... March 23, 2017 , ... The ... 3rd location in the greater Houston Area. The new location is located at 2255 ... Luke’s Hospital in Springwoods Village. This newest location will provide patients living in the ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... Center at 10 North Broadway Avenue, will be an educational and exciting program ... instruction in the management of chronic pain. , Oklahoma is in a healthcare ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Mar. 24, 2017 Research and Markets ... the U.S.: Consumer Strategies" report to their offering. ... Pain ... approach and treat their physical pain, emphasizing consumer survey analysis, ... pain sufferers and adults who have selected illnesses/conditions strongly associated ...
(Date:3/24/2017)... , March 24, 2017 ShangPharma, ... high-quality and cost-effective drug development and discovery ... and biotechnology industry, announced today the intent ... ShangPharma will be consolidating the Contract Research ... under Shanghai ChemPartner. These entities include ChemPartner ...
(Date:3/24/2017)... , Mar. 24, 2017 Research and Markets ... Pipeline Analysis, 2016" report to their offering. ... The IPF pipeline is very strong with a ... Merck & Co., Inc., Biogen and Sanofi are involved in the development ... of which one is in Phase III stage, 15 are in Phase ...
Breaking Medicine Technology: